Precision Biologics
Precision Biologics, a Texas-based biotech firm, develops therapeutic and diagnostic products.
Founded
2012Precision Biologics, a Texas-based biotech firm, develops therapeutic and diagnostic products.
Founded in Dallas, Texas, Precision Biologics is a biotechnology company dedicated to developing innovative therapeutic and diagnostic products. Their core mission is to advance healthcare through precision medicine, focusing on creating targeted treatments and diagnostic tools for cancer and other serious diseases. The company's offerings include a range of companion diagnostics and therapeutics designed to improve patient outcomes by providing more precise and effective medical solutions.
Precision Biologics has attracted notable figures in the biotech industry to its board and leadership team, contributing to its strategic direction and growth. The company has achieved significant milestones in its clinical pipeline, including successful clinical trials and the development of a unique discovery platform. Through its cutting-edge research and development efforts, Precision Biologics has made a substantial impact on the field of precision medicine, aiming to transform the landscape of cancer treatment and diagnostics.
Companies similar to Precision Biologics include Precede Biosciences, Precision Theranostics, AI Therapeutics and Precision IBD.
Precision Biologics was founded in 2012.
Precision Biologics' headquarters is located in Dallas, TX, US.
Precision Biologics' most recent funding round was for $50M (USD) in October 2015.
As of Oct 16, 2015, Precision Biologics has disclosed funding of $59.4M (USD). Undisclosed round amounts are excluded.
Precision Biologics has 11 employees as of Feb 4, 2024.
Precision IBD
